Вакцинация против вирусного гепатита B у детей при трансплантации печени
https://doi.org/10.15825/1995-1191-2017-4-124-129
Аннотация
Надежная защита от гепатит-В-вирусной (HBV) инфекции и других управляемых инфекционных заболеваний у детей имеет существенное значение в связи с улучшениями показателей отдаленной выживаемости реципиентов и трансплантатов после трансплантации печени. В настоящее время имеются только ограниченные данные об иммуногенности вакцин у детей при трансплантации. Обзор литературы представляет информацию о текущем подходе к проведению вакцинации против HBV-инфекции, принятых графиках вакцинации, целевых показателях уровня специфических антител до и после трансплантации печени детям. Также представлена информация о различных типах вакцин для провилактики HBV-инфекции и эффективности вакцинации в различных трансплантационных центрах.
Об авторах
И. В. Жилкин
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России.
Россия
Москва.
Россия
Москва.
О. М. Цирульникова
Кафедра трансплантологии и искусственных органов ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет); ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России.
Россия
Москва.
Россия
Москва.
Список литературы
1. Готье СВ, Константинов БА, Цирульникова ОМ. Трансплантация печени. М.: МИА, 2008. Gautier SV, Konstantinov BA, Tsirulnikova OM. Transplantatsiya pecheni. M.: MIA, 2008.
2. Danzinger-Isakov L, Kumar D. Guidelines for Vaccination of Solid Organ Transplant Candidates and Recipients. Am. J. Transplant. Dec. 2009; 9: S258–S262.
3. Weinbaum CM, Mast EE, and Ward JW. Recommendations for identifi cation and public health management of persons with chronic hepatitis B virus infection. Hepatology. May 2009; 49; S5: S35–S44.
4. HBV FAQs for Health Professionals | Division of Viral Hepatitis | CDC. [Online]. Available: https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm. [Accessed: 19-Sep-2017].
5. WHO | Hepatitis B, WHO. [Online]. Available: http:// www.who.int/mediacentre/factsheets/fs204/en/. [Accessed: 19-Sep-2017].
6. Romo EM et al. Peripheral Blood Lymphocyte Populations in End-stage Liver Diseases. J. Clin. Gastroenterol. Aug. 2007; 41; 7: 713–721.
7. Diana A, Posfay-Barbe KM, Belli DC, and Siegrist C-A. Vaccine-induced immunity in children after orthotopic liver transplantation: A 12 year review of the Swiss national reference center. Pediatr. Transplant. Feb. 2007; 11; 1: 31–37.
8. Rokuhara A et al. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome. J. Med. Virol. Dec. 2000; 62; 4: 471–478.
9. Wachs ME et al. The Risk of Transmission of Hepatitis B From Hbsag(–), Hbcab(+), Hbigm(–) Organ Donors. Transplantation. Jan. 1995; 59; 2: 230.
10. Uemoto S et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. Feb. 1998; 65; 4: 494–499.
11. Dickson R et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. Nov. 1997; 113; 5: 1668–1674.
12. Leung DH, Ton-That M, Economides JM, and Healy CM. High Prevalence of Hepatitis B Nonimmunity in Vaccinated Pediatric Liver Transplant Recipients. Am. J. Transplant. Feb. 2015; 15; 2: 535–540.
13. ACIP Vaccine Recommendations | CDC. [Online]. Available: https://www.cdc.gov/vaccines/hcp/acip-recs/index.html. [Accessed: 21-Sep-2017].
14. Changes to the Vaccination Schedule Recommended by the Japan Pediatric Society. October 1, 2016.
15. Приказ Министерства здравоохранения РФ от 21 марта 2014 г. № 125н «Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям». Prikaz Ministerstva zdravoohraneniya RF ot 21 marta 2014 g. № 125n «Ob utverzhdenii nacional’nogo kalendarya profi lakticheskih privivok i kalendarya profi lakticheskih privivok po ehpidemicheskim pokazaniyam».
16. Mast E. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults. [Online]. Available: https://www.cdc.gov/Mmwr/preview/mmwrhtml/rr5516a1.htm.
17. Duval B et al. Comparative Long Term Immunogenicity of Two Recombinant Hepatitis B Vaccines and the Effect of a Booster Dose Given After Five Years in a Low Endemicity Country. Pediatr. Infect. Dis. J. Mar. 2005; 24; 3: 213–218.
18. Burroughs M. and Moscona A. Immunization of Pediatric Solid Organ Transplant Candidates and Recipients. Clin. Infect. Dis. Jun. 2000; 30; 6: 857–869.
19. Castells L and Esteban R. Hepatitis B vaccination in liver transplant candidates. Eur. J. Gastroenterol. Hepatol. Apr. 2001; 13; 4: 359–361.
20. Danziger-Isakov L, Kumar D. Vaccination in Solid Organ Transplantation. Am. J. Transplant. Mar. 2013; 13; s4: 311–317.
21. Leung DH, Ahamba DC, Pillai LN, Khan MF, Smith EO, and Mahoney DH. Unrecognized hepatitis B in prescreened children with hematologic and oncologic conditions. Pediatr. Blood Cancer. May 2014; 61; 5: 865– 868.
22. Su W-J et al. High-Titer Antibody to Hepatitis B Surface Antigen Before Liver Transplantation Can Prevent De Novo Hepatitis B Infection. J. Pediatr. Gastroenterol. Nutr. Feb. 2009; 48; 2: 203–208.
23. L’Huillier AG et al. Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: A 19 year review of the Swiss national reference center. Pediatr. Transplant. Feb. 2012; 16; 1: 50–57.
24. Günther M, Neuhaus R, Bauer T, Jilg W, Holtz JA, and Bienzle U. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: Antibody decline and booster vaccination with conventional vaccine. Liver Transpl. Feb. 2006; 12; 2: 316–319.
25. Evangeliou H, Coic L, Barbaros A, Tapiero B, Buteau C, and Alvarez F. Hepatitis B Immunization in Pediatric Solid Organ Transplant Recipients. Open Forum Infect. Dis. Dec. 2015; 2; suppl. 1.
26. Yoshizawa A et al. Long-term effi cacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts. Hepatol. Res. May 2016; 46; 6: 541–551.
27. Lee S et al. De novo hepatitis B prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody–positive livers. Liver Transpl. Feb. 2016; 22; 2: 247–251.
28. Lee KW et al. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation. Transplant. Proc. Oct. 2004; 36; 8: 2311–2312.
29. Park JB et al. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. Transpl. Int. Apr. 2008; 21; 4: 346–352.
30. Yi N-J et al. Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. Mar. 2007; 13; 3: 451– 458.
31. Samuel D et al. Liver Transplantation in European Patients with the Hepatitis B Surface Antigen. N. Engl. J. Med. Dec. 1993; 329; 25: 1842–1847.
32. McGory RW et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation. May 1996; 61; 9: 1358–1364.
33. Kwon CHD et al. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation. Pediatr. Transplant. Jun. 2006; 10; 4: 479–486.
34. Chalasani N, Smallwood G, Halcomb J, Fried MW, and Boyer Thomas D. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl. Surg. Mar. 1998; 4; 2: 128–132.
35. Arslan M, Wiesner RH, Sievers C, Egan K, and Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl. Apr. 2001; 7; 4: 314–320.
36. Loinaz C et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology. 1997; 44; 13: 235–238.
37. Engler SH et al. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur. J. Gastroenterol. Hepatol. Apr. 2001; 13; 4: 363–367.
38. Duca P, Del Pont JM, and D’Agostino D. Successful Immune Response to a Recombinant Hepatitis B Vaccine in Children After Liver Transplantation. J. Pediatr. Gastroenterol. Nutr. Feb. 2001; 32; 2: 168–170.
39. Sokal EM, Ulla L, and Otte JB. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig. Dis. Sci. Aug. 1992; 37; 8: 1250–1252.
40. Avery RK and Michaels M. Update on Immunizations in Solid Organ Transplant Recipients: What Clinicians Need to Know. Am. J. Transplant. Jan. 2008; 8; 1: 9–14.
41. Szmuness W et al. Hepatitis B vaccine: demonstration of effi cacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. Oct. 1980; 303; 15: 833–841.
42. Stephenne J. Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine. Mar. 1990; 8 Suppl: S69–73; discussion S79–80.
43. Young MD et al. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine. Hepatol. Baltim. Md. Aug. 2001; 34; 2: 372–376.
44. Lo C-M, Lau GK, Chan S-C, Fan S-T, and Wong J. Effi cacy of a Pre-S Containing Vaccine in Patients Receiving Lamivudine Prophylaxis after Liver Transplantation for Chronic Hepatitis B. Am. J. Transplant. Feb. 2007; 7; 2: 434–439.
Рецензия
Для цитирования:
Жилкин И.В., Цирульникова О.М. Вакцинация против вирусного гепатита B у детей при трансплантации печени. Вестник трансплантологии и искусственных органов. 2017;19(4):124-129. https://doi.org/10.15825/1995-1191-2017-4-124-129
For citation:
Zhilkin V.I., Tsiroulnikova O.M. Vaccination against viral hepatitis b in pediatric liver transplant recipients. Russian Journal of Transplantology and Artificial Organs. 2017;19(4):124-129. (In Russ.) https://doi.org/10.15825/1995-1191-2017-4-124-129
Просмотров: 922
Послать статью по эл. почте 